Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Corrigendum to "Rapamycin suppresses TLR4-triggered IL-6 and PGE(2) production of colon cancer cells by inhibiting TLR4 expression and NF-kappaB activation" [Mol. Immunol. 45 (2008) 2929-2936].
Mol Immunol. 2020 May 17;122:222. doi: 10.1016/j.molimm.2020.05.003. Online ahead of print.
Mol Immunol. 2020.
PMID: 32434116
No abstract available.
Rapamycin suppresses TLR4-triggered IL-6 and PGE(2) production of colon cancer cells by inhibiting TLR4 expression and NF-kappaB activation.
Sun Q, Liu Q, Zheng Y, Cao X.
Sun Q, et al.
Mol Immunol. 2008 May;45(10):2929-36. doi: 10.1016/j.molimm.2008.01.025. Epub 2008 Mar 17.
Mol Immunol. 2008.
PMID: 18343502
In the present study, we demonstrate that rapamycin can significantly inhibit TLR4-triggered IL-6 and PGE(2) production and invasion of colon cancer cells. ...Furthermore, disruption of NF-kappaB …
In the present study, we demonstrate that rapamycin can significantly inhibit TLR4-triggered IL-6 …
Item in Clipboard
Cite
Cite